神经生长因子IB
造血
下调和上调
生物
癌症研究
髓样
免疫学
核受体
骨髓
贫血
糖尿病
祖细胞
内分泌学
红细胞生成
细胞生物学
干细胞
造血干细胞
白血病
髓系白血病
医学
内科学
受体
作者
Qiao‐ling Huang,Deyi Feng,Yinxiang Huang,Qi-Tao Chen,Wenxiu Zhao,Xiao-xue Li,Qian Xiao,Heng-hui Li,Wu Rong,Yi Zhang,Yue Chen,李学均,Qiao Wu,Caoxin Huang,Hang‐zi Chen
出处
期刊:Blood
[Elsevier BV]
日期:2026-11-10
标识
DOI:10.1182/blood.2026034088
摘要
Anemia is a prevalent but poorly understood complication of diabetes mellitus. Here, we identify orphan nuclear receptor Nur77 as a critical suppressor of diabetic anemia. Nur77 expression was downregulated in hematopoietic stem and progenitor cells (HSPCs) from diabetic patients with anemia. In multiple diabetic mouse models, knockout of Nur77 induced anemia, a phenotype recapitulated by bone marrow transplantation. Mechanistically, Nur77 functioned as a transcriptional repressor in HSPCs, whose deficiency, together with diabetes-associated epigenetic modifications, enhanced chromatin accessibility and expression of genes involved in myeloid leukocyte differentiation. Consequently, this led to myeloid leukocyte-biased differentiation of HSPCs at the expense of erythroid lineage. Pharmacological upregulation of Nur77 with its agonist cytosporone B (Csn-B) effectively prevented anemia in diabetic mice. Clinically, Nur77 levels in HSPCs of diabetic patient negatively correlated with anemia occurrence. Collectively, our findings reveal a novel Nur77-mediated pathway in diabetic anemia pathogenesis and propose Nur77 as a new therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI